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Lupus Nephropathy S55antineutrophil cytoplasmic autoantibodies (ANCA) in assessing the prognosis
of refractory severe lupus nephritis (LN).
Methods: Eighty-four cases of refractory severe LN were randomly divided into
twogroupsof 42caseseach:CTXgroupandRTXgroup(CTX+RTX)duringFebruary
2010 to February 2014 in our hospital and First Affiliated Hospital of Zhengzhou
University. Changes in serum levels of anti-C1q antibodies and ANCA in the two
groups were examined, and efficacies of the drugs were compared.
Results: The total efficacy of RTX group was found to be 83.3 %, which was
significantly higher than that of the CTX group, 57.1 % (p< 0.05). The serum
anti-C1q antibodies and ANCA were decreased to 11.9% and 26.2 % in the
RTX-treated group, which was significantly lower than those observed in
the CTX-treated patients (21.4% and 69.0 % respectively) (p< 0.05). The
clinical indices of LN were significantly improved in the two groups after
the treatment. However, the urinary protein, albumin, complement C3,
the percentage of CD19+ B cells, and SLEDAI scores in the RTX group were
significantly lower than those in the CTX group (p< 0.05).
Conclusion: RTX plus CTX showed a better therapeutic efficacy compared to
single CTX, and it significantly improved the prognosis of refractory and se-
vere LN. Anti-C1q antibody and ANCA level may be valuable biomarkers for
the prognosis of LN.http://dx.doi.org/10.1016/j.hkjn.2015.08.143
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Low-dose Mycophenolate Mofetil in the Treatment of Lupus Nephritis
Ling An, Wenbo Hu
The Qinghai Provincial People’s Hospital, Qinghai, China
Objective: To evaluate the efficacy of low-dose mycophenolate mofetil
(MMF) combined with low-dose prednisone in the treatment of lupus
nephritis.
Methods: Forty patients (5 males, 35 females) with lupus nephritis (10 in
class III, 18 in class IV, 12 in class V+IV) were treated with low-dose MMF
(1.0 g/d to 1.5 g/d) combined with prednisone 0.35 mg/(kg$d), course of
12 months, changes were observed before and after treatment in January,
March, June, September, December liver and kidney function, blood uric
acid, cholesterol, blood sugar, blood coagulation, urine, 24-hour urinary pro-
tein, serum antibody levels and other indicators.
Results: Complete remission in 28 patients (70%), partial remission in 8 pa-
tients (20%), and no relief in 4 patients (10), the total efficiency of 90%. Low-
doses of MMF combined with low-dose prednisone treatment of lupus
nephritis had no effect on liver function, creatinine, glucose, uric acid,
white blood cells, platelets. Treatment 1e3 months, plasma protein
increased, decreased 24-hour urinary protein, blood lipid levels decreased
(P< 0.05), 6e12 months after treatment significantly increased serum
albumi hemoglobin, and 24-hour urinary protein, blood lipid levels, serum
antibody levels were significantly decreased (P< 0.01). Only 1 case of infec-
tion occurred in 40 patients discontinued.
Conclusion: Low-dose MMF in combination with low-dose prednisone is
effective in treating lupus nephritis, has better treatment safety, and low
incidence of infection.http://dx.doi.org/10.1016/j.hkjn.2015.08.144
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Functional MRI Used to Evaluate Renal Hypoxia in Mice with Lupus
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Objectives: To investigate the utility of diffusion weighted imaging (DWI)
and blood oxygen level-dependent (BOLD) MR imaging in the assessment ofrenal hypoxia in an experimental model of mice with established lupus
nephritis (LN).
Methods: Sixteen-week-old female MRL/lpr mice (n Z 13) were studied
and 14 week old male C57BL/6 mice (n Z 10) served as controls. The
mice underwent coronal echo-planar DWI and BOLD MR imaging of the
kidneys. Hypoxyprobe was administed intraperitoneally to the mice 1
hour before they were sacrificed. The distribution of HypoxyprobeTM-1,
hypoxia-inducible factor 1a (HIF-1a) and heme oxygenase-1 (HO-1) in
renal tissues were detected by immunohistochemical analyses and West-
ern blot. The apparent diffusion coefficient (ADC) and R2* value of the
kidneys was calculated with b values of 0 and 500 s/mm2. The relation be-
tween the renal hypoxia parameters and the ADCs or R2* values were
evaluated.
Results: Glomerular mesangial proliferation and basement membrane
thickening, tubular epithelial cells damage, interstitial leukocytes infiltra-
tion, especially the large accumulation of inflammatory cells surrounding
small vessels were observed in MRL/lpr mice. It was found that Hypoxypro-
beTM-1, HIF-1a and HO-1 distributed widely in the renal tissues of MRL/lpr
mice, and closely associated with the renal tubulointerstitial lesions. The
mean ADC values of kidneys in MRL/lpr mice were 1.52  0.27 x 10－
3 mm2/s, the mean R2* values of the renal cortex and medulla were
30.95  4.59/sec and 23.43  3.06/sec respectively, which were all signif-
icantly lower than that in C57BL/6 mice (p Z 0.037, p Z 0.03 and
pZ 0.043, respectively). The mean R2* values were negatively correlated
with the degree of tubulointerstitial lesions and the expression of hypoxia
parameters.
Conclusion: The results suggested that renal hypoxia is one of the key fac-
tors leading to renal tubulointerstitial lesion, and functional MRI may used to
monitor renal hypoxia in LN.
*Funding was provided by the National Natural Science Foundation of China
(81170671).http://dx.doi.org/10.1016/j.hkjn.2015.08.145
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Monocyte Chemotactic Protein-1, Fractalkine and Receptor for
Advanced Glycation End Products in Different Pathological Types of
Lupus Nephritis and Their Value in Predicting Treatment Prognosis
L. Lan, F. Han, J. H. Chen
Kidney Disease Center, The First Affiliated Hospital, College of Medicine,
Zhejiang University, Hangzhou, China
Objective: Early diagnosis is important for the outcome of lupus nephritis
(LN). But the pathological type of LN is closely related to the clinical man-
ifestations, and hence the treatment of LN depends on different patholog-
ical types. To assess the level of monocyte chemotactic protein (MCP-1),
fractalkine (Fkn), and receptor for advanced glycation end product
(RAGE) in different pathological types of lupus nephritis and to explore
the value of these biomarkers in predicting the prognosis of lupus
nephritis.
Methods: In the patients included in this study, through renal biopsy, class III
and class IV were defined as proliferative group, class V as nonproliferative
group, class V+III and class V+IV as mixed group. During the follow-up, 40 of
the 178 enrolled patients were found to have poor response to standard
immunosuppressant therapy. The level of markers in the different response
groups was tested.
Results: The levels of urine and serum MCP-1, urine and serum Fkn, and
serum RAGE were higher in the proliferative group, and lower in the nonpro-
liferative group, and the difference was significant. The levels of urine and
serum MCP-1 and serum RAGE were lower in the poor response group; the
difference was also significant. The relationship between urine MCP-1, urine
and serum Fkn with the Systemic Lupus Erythematosus Disease Activity Index
was proved.
Conclusion: The concentration of cytokines MCP-1, Fkn, and RAGE may be
correlated with the nuclear factor-kappaB pathway. The urine and serum
MCP-1 and serum RAGE may help in predicting the prognosis before standard
immunosuppressant therapy.
S56 Lupus Nephropathyhttp://dx.doi.org/10.1016/j.hkjn.2015.08.146
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Successful Treatment for Lupus Podocytopathy with Prolonged Course
of Corticosteroid
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Background: Lupus podocytopathy was recently recognized as a distinct en-
tity of lupus nephritis apart from those described in ISN/RPS 2003
classification.
Case Summary: We report a 16-year-old girl who presented with bilateral
lower limb edema and peri-orbital puffiness for 2 weeks. She had no skin
rash, joint pain nor hematuria. She did not take any over-the-counter med-
ications. Her younger sister had biopsy proven lupus nephritis 3 years prior
and was treated with steroid. Laboratory investigations showed proteinuria
7.52 g/d, serum albumin 15.3 g/L, creatinine 51 umol/L, total cholesterol
14.36 mmol/L, ANA titre 1:160, presence of anti-ENA antibody and anti-Ro
antibody, anti-dsDNA >300 IU/ml and C3 0.25 g/L. Renal biopsy showed
diffuse global mesangial hypercellularity with increased mesangial matrix.
There was no endocapillary proliferation and the glomerular basement
membrane was normal. Direct immunofluorescence study showed diffuseglobal mesangial staining for IgG, IgA, IgM, C3 and C1q. Electron microscopy
revealed near-complete effacement of podocytic foot processes with micro-
villous hyperplasia. There were diffuse medium to large mesangial and para-
mesangial immune complex deposits, while only focal scattered small
immune complex deposits were noted in the subendothelial and subepithe-
lial compartment. The diagnosis was class II lupus nephritis with podocytop-
athy. She was treated with high dose prednisolone (1 mg/kg/d) for 4 weeks
and then tapered down slowly. Azathioprine was added in the 5th month as
steroid-sparing agent. She had gradual serological improvement and the pro-
teinuria nearly subsided with normal serum albumin at 14 months.
Conclusion: This case illustrates that lupus podocytopathy can be managed
by prolonged course of corticosteroid. However, further study is required to
investigate the optimal treatment strategy and duration for the condition.http://dx.doi.org/10.1016/j.hkjn.2015.08.147
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Persistence of Low Serum C3 Level is Associated with Higher Relapse
Rate and Influences Prognosis in Lupus Nephritis
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Objective: To investigate the influence of persistent hypocomplementemia
on lupus nephritis (LN) activity and prognosis.
Methods: This retrospective study included 39 patients with renal biopsy-
proven active LN [2 of class II, 5 of class III, 17 of class IV, 7 of class V, 2
of class V+III, and 4 of class V+IV; 2 male, 37 female; median age
36.46  11.72 (range 16e68) years, average follow-up 60.18  33.48 (range
24e142) months], and persistent low serum C3 lasting for more than 2 years.
At the initial stage, 17 of 39 (43.59%) had nephrotic proteinuria (> 3.5 g/
day), and 2 of 39 (5.13%) had acute kidney injury. In addition, serum C4 level
was 7.75  5.92 (range 4e29) mg/L, ANA titer was 194.36  130.50, and
eGFR was 91.64  29.09 (range 24.3e137) ml/min/1.73 m2. 18 cases
(46.15%) had positive anti-dsDNA. Student’s paired t-test analysis was used
for statistical evaluation.
Results: The serum C3 levels were below normal (35.78  14.06; range
17.5e63.8 mg/L) at baseline and continued to last (51.02  12.99; range
15.0e70.8 mg/L), though the last C3 levels were higher than the baseline
(P Z 0.001). In the 6th month, 26 cases (66.67%) had achieved complete
remission, 9 cases (23.08%) had partial remission, and 4 cases had no
response. During the 9e113th month, 19 cases (48.72%) had nephritis
relapse, and 9 cases (23.08%) had decreased eGFR dropping from
86.11  27.75 (range 49.3e116.5) ml/min/1.73 m2 to 35.92  24.1 (range
8.47e74.9) ml/min/1.73 m2 (P Z 0.001).
Conclusion: Persistence of low serum C3 level is associated with higher
relapse rate and influences prognosis in lupus.http://dx.doi.org/10.1016/j.hkjn.2015.08.148
